Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
Arterial Stiffness Inc. (ASI), also known as Arterial Assessments, has developed an affordable, portable, and non-invasive device that measures the amount of atherosclerosis a person has (plaque in their arteries).
Competitive devices used to measure atherosclerosis require a technician to operate and cost approximately $25,000. But ASI’s device does not require a technician, has a more efficient capital model, and determines a person’s stiffness index in less than two minutes.
ASI earns revenue through product sales and monthly subscription models. Its target customers are primary care physician offices.
Contact Info500-321 McDermot Ave Winnipeg R3A 0A3 MB Canada
P: 1 204 272 2406